ANI Expects Growth From Launches And Novitium Integration
As Company Expects Cortrophin Gel To Have Commercial Longevity
ANI Pharma has outlined key pillars of its strategy to drive growth in the coming quarters as the company reported a slight increase in revenues in the fourth quarter of 2021. The company’s recent purified Cortrophin Gel launch is off to a good start, as ANI leadership counts on its commercial longevity.
